Axiomhealth Management Llc | |
1180 Spring Centre South Blvd Ste 225 Altamonte Springs FL 32714-1991 | |
(407) 494-0644 | |
(407) 494-0644 |
Full Name | Axiomhealth Management Llc |
---|---|
Speciality | Clinic/Center |
Location | 1180 Spring Centre South Blvd Ste 225, Altamonte Springs, Florida |
Authorized Official Name and Position | Dustin Patric Moura (REGISTERED AGENT) |
Authorized Official Contact | 4073124613 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Axiomhealth Management Llc 1180 Spring Centre South Blvd Ste 225 Altamonte Springs FL 32714-1991 Ph: (407) 495-1165 | Axiomhealth Management Llc 1180 Spring Centre South Blvd Ste 225 Altamonte Springs FL 32714-1991 Ph: (407) 494-0644 |
NPI Number | 1912456799 |
---|---|
Provider Enumeration Date | 09/22/2016 |
Last Update Date | 03/18/2024 |
Certification Date | 03/18/2024 |
Medicare PECOS PAC ID | 3072897602 |
---|---|
Medicare Enrollment ID | O20170228000464 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1912456799 | NPI | - | NPPES |
019968100 | Medicaid | FL | |
045208 | Other | FL | UNITED HEALTHCARE (OPTUM) |
Provider Name | Randi C Bonner |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1013987338 PECOS PAC ID: 4284650789 Enrollment ID: I20051027000423 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Chy Ching Chuang |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1609055953 PECOS PAC ID: 1759450448 Enrollment ID: I20080521000336 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Marcia Regina Roman |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1063774974 PECOS PAC ID: 5193976801 Enrollment ID: I20121106000192 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Deborah D Moura |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1285779280 PECOS PAC ID: 9133342744 Enrollment ID: I20140529002167 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Hillary A Monsour |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1003156738 PECOS PAC ID: 0941501779 Enrollment ID: I20151219000120 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Jigar D Vyas |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1073996310 PECOS PAC ID: 3779474218 Enrollment ID: I20160509002049 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Justine Alexis Nierras |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1164870978 PECOS PAC ID: 8628321486 Enrollment ID: I20181024000430 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Elizabeth Seely |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1821621657 PECOS PAC ID: 4880019637 Enrollment ID: I20200811000223 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Ariel A Aure |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1700057973 PECOS PAC ID: 5092121178 Enrollment ID: I20210316000937 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Irene Lardizabal |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1295909018 PECOS PAC ID: 5991171696 Enrollment ID: I20221020003475 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Robert Matthew Sockol |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1942613229 PECOS PAC ID: 1557692423 Enrollment ID: I20230323002857 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Provider Name | Briana Nicole Kidd |
---|---|
Provider Type | Practitioner - Physical Therapist In Private Practice |
Provider Identifiers | NPI Number: 1629540059 PECOS PAC ID: 0547626517 Enrollment ID: I20230517000702 |
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
News Archive
In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.
Nektar Therapeutics reported that partner AstraZeneca announced today that MOVANTIK (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC) in adult patients with chronic, non-cancer pain.
Although a pooling of data from 12 studies showed a statistically significant association between use of lateral wedge insoles and lower pain in medial knee osteoarthritis, among trials comparing wedge insoles with neutral insoles, there was no significant or clinically important association between use of wedge insoles and reduction in knee pain, according to a study in the August 21 issue of JAMA.
Diabetes affects almost 400 million people worldwide. One of the hallmarks of this disease is a loss of pancreatic β cells, which secrete insulin. In many patients the reduction of β cells is associated an accumulation of a toxic form of a protein produced by β cells, known as islet amyloid polypeptide.
VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.
› Verified 8 days ago
Parkinsons & Movement Disorders Clinic Of Orlando, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 106 Boston Ave, Suite 204, Altamonte Springs, FL 32701 Phone: 407-723-7172 Fax: 407-423-9505 | |
Wellness Institute Of Orlando Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 851 W Sr 436, 1089, Altamonte Springs, FL 32714 Phone: 407-786-0600 Fax: 407-786-0650 | |
Burlacher And Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 110 Spring Lake Hills Dr, Altamonte Springs, FL 32714 Phone: 407-312-9221 Fax: 407-869-1403 | |
Personal Dynamics, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 711 Ballard St, Altamonte Springs, FL 32701 Phone: 407-869-1776 | |
Joseph N Deluca, Phd, Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 378 Centerpointe Circle, Suite 1280, Altamonte Springs, FL 32701 Phone: 407-862-5959 Fax: 407-774-5573 | |
Maribel Sharing Hope Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 978 Douglas Ave Ste 700, Altamonte Springs, FL 32714 Phone: 407-754-6967 | |
Pebble Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 527 San Sebastian Prado, Altamonte Springs, FL 32714 Phone: 407-603-5296 |